Qiagen N.V. (VIE:QGE3)

Market Cap	9.08B
Revenue (ttm)	1.74B
Net Income (ttm)	317.94M
Shares Out	n/a
EPS (ttm)	1.44
PE Ratio	28.54
Forward PE	19.93
Dividend	1.42 (3.38%)
Ex-Dividend Date	Jul 2, 2025

Volume	n/a
Average Volume	n/a
Open	41.98
Previous Close	42.00
Day's Range	41.98 - 42.23
52-Week Range	35.38 - 47.34
Beta	n/a
RSI	69.44
Earnings Date	Oct 26, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: QGE3

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD